Biocryst Pharmaceuticals buy Evercore ISI
Start price
20.04.23
/
50%
€6.67
Target price
20.04.24
€9.11
Performance (%)
-38.50%
End price
21.04.24
€4.10
Summary
This prediction ended on 21.04.24 with a price of €4.10. Massive losses of -38.50% were the result for the BUY prediction by Evercore_ISI. Evercore_ISI has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. Evercore_ISI has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biocryst Pharmaceuticals | -7.413% | -7.413% | -14.962% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Evercore_ISI for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target lowered by analysts at Evercore ISI from $13.00 to $10.00. They now have an "outperform" rating on the stock.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten
Current prediction by Evercore_ISI for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.73
13.01.25
13.01.25
€11.76
13.01.26
13.01.26
-21.43%
17.12.25
17.12.25
